The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Orexinergic System Dysregulation, Sleep Impairment, and Cognitive Decline in Alzheimer Disease
Abstract
IMPORTANCE: Nocturnal sleep disruption develops in Alzheimer disease (AD) owing to the derangement of the sleep-wake cycle regulation pathways. Orexin contributes to the regulation of the sleep-wake cycle by increasing arousal levels and maintaining wakefulness. OBJECTIVES: To study cerebrospinal fluid levels of orexin in patients with AD, to evaluate the relationship of orexin cerebrospinal fluid levels with the degree of dementia and the cerebrospinal fluid AD biomarkers (tau proteins and β-amyloid 1-42), and to analyze potentially related sleep architecture changes measured by polysomnography. DESIGN, SETTING, AND PARTICIPANTS: We conducted a case-control study from August 1, 2012, through May 31, 2013. We included 48 drug-naive AD patients referred to the Neurological Clinic of the University Hospital of Rome Tor Vergata. Based on the Mini-Mental State Examination score, 21 patients were included in mild AD group (score, ≥21), whereas 27 were included in the moderate to severe AD group (score, <21). The control group consisted of 29 nondemented participants of similar age and sex. EXPOSURE: Laboratory assessment of cerebrospinal fluid levels of orexin, tau proteins, and β-amyloid 1-42 and polysomnographic assessment of sleep variables. MAIN OUTCOMES AND MEASURES: Levels of orexin, tau proteins, and β-amyloid 1-42; macrostructural variables of nocturnal sleep (total sleep time, sleep efficiency, sleep onset and rapid eye movement [REM] sleep latencies, non-REM and REM sleep stages, and wakefulness after sleep onset); and Mini-Mental State Examination scores. RESULTS: Patients with moderate to severe AD presented with higher mean (SD) orexin levels compared with controls (154.36 [28.16] vs 131.03 [26.55]; P < .01) and with more impaired nocturnal sleep with respect to controls and patients with mild AD. On the other hand, in the global AD group, orexin levels were positively correlated with total tau protein levels (r = 0.32; P = .03) and strictly related to sleep impairment. Finally, cognitive impairment, as measured by the Mini-Mental State Examination, was correlated with sleep structure deterioration. CONCLUSIONS AND RELEVANCE: Our results demonstrate that, in AD, increased cerebrospinal fluid orexin levels are related to a parallel sleep deterioration, which appears to be associated with cognitive decline. Therefore, the orexinergic system seems to be dysregulated in AD, and its output and function appear to be overexpressed along the progression of the neurodegenerative process. This overexpression may result from an imbalance of the neurotransmitter networks regulating the wake-sleep cycle toward the orexinergic system promoting wakefulness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
The ten-twenty electrode system of the international federation
Jasper, H. H. (1958) · Electroencephalography and Clinical Neurophysiology · Cited by 6,567
(2007) · Cited by 6,530
Sleep Drives Metabolite Clearance from the Adult Brain
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., et al. (2013) · Science · doi:10.1126/science.1241224 · Cited by 5,411
Hypothalamic regulation of sleep and circadian rhythms
Saper, C. B., Scammell, T. E., & Lu, J. (2005) · Nature · doi:10.1038/nature04284 · Cited by 2,804
Amyloid-β Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle
Kang, J.-E., Lim, M. M., Bateman, R. J., Lee, J. J., Smyth, L. P., Cirrito, J. R., Fujiki, N., Nishino, S., & Holtzman, D. M. (2009) · Science · doi:10.1126/science.1180962 · Cited by 1,565
CSF markers for incipient Alzheimer's disease
Blennow, K., & Hampel, H. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00530-1 · Cited by 1,291
Orexin A activates locus coeruleus cell firing and increases arousal in the rat
Hagan, J. J., Leslie, R. A., Patel, S., Evans, M. L., Wattam, T. A., Holmes, S., Benham, C. D., Taylor, S. G., Routledge, C., Hemmati, P., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10911 · Cited by 1,234
Discharge of Identified Orexin/Hypocretin Neurons across the Sleep-Waking Cycle
Lee, M. G., Hassani, O. K., & Jones, B. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1887-05.2005 · Cited by 871
Acetylcholine in mind: a neurotransmitter correlate of consciousness?
Perry, E., Walker, M., Grace, J., & Perry, R. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01361-7 · Cited by 763
Sleep Quality and Preclinical Alzheimer Disease
Ju, Y.-E. S., McLeland, J. S., Toedebusch, C. D., Xiong, C., Fagan, A. M., Duntley, S. P., Morris, J. C., & Holtzman, D. M. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.2334 · Cited by 744
Roh, J. H., Huang, Y., Bero, A. W., Kasten, T., Stewart, F. R., Bateman, R. J., & Holtzman, D. M. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004291 · Cited by 563
Li, Y., Gao, X.-B., Sakurai, T., & van den Pol, A. N. (2002) · Neuron · doi:10.1016/s0896-6273(02)01132-7 · Cited by 461
The hypocretin/orexin ligand–receptor system: implications for sleep and sleep disorders
Kilduff, T. S., & Peyron, C. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01594-0 · Cited by 438
Sleep Problems and Institutionalization of the Elderly
Pollak, C. P., & Perlick, D. (1991) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879100400405 · Cited by 395
In-office mental status testing: a practical guide.
Mungas, D. (1991) · PubMed · Cited by 298
Vitiello, M. V., & Borson, S. (2001) · CNS Drugs · doi:10.2165/00023210-200115100-00004 · Cited by 275
Sleep disorders in Alzheimer's disease and other dementias
Bliwise, D. L. (2004) · Clinical Cornerstone · doi:10.1016/s1098-3597(04)90014-2 · Cited by 272
Hypocretin (orexin) loss in Alzheimer's disease
Fronczek, R., van Geest, S., Frölich, M., Overeem, S., Roelandse, F. W. C., Lammers, G. J., & Swaab, D. F. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.03.014 · Cited by 254
Sleep Disturbances in Patients With Mild-Stage Alzheimer's Disease
Vitiello, M. V., Prinz, P. N., Williams, D. E., Frommlet, M. S., & Ries, R. K. (1990) · Journal of Gerontology · doi:10.1093/geronj/45.4.m131 · Cited by 223
van Harten, A. C., Visser, P. J., Pijnenburg, Y. A. L., Teunissen, C. E., Blankenstein, M. A., Scheltens, P., & van der Flier, W. M. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.08.004 · Cited by 197
Is there a link between sleep changes and memory in Alzheimer's disease?
Rauchs, G., Schabus, M., Parapatics, S., Bertran, F., Clochon, P., Hot, P., Denise, P., Desgranges, B., Eustache, F., Gruber, G., et al. (2008) · NeuroReport · doi:10.1097/wnr.0b013e32830867c4 · Cited by 179
Sleep/wake patterns In Alzheimer's disease: relationships with cognition and function
MOE, K. E., VITIELLO, M. V., LARSEN, L. H., & PRINZ, P. N. (1995) · Journal of Sleep Research · doi:10.1111/j.1365-2869.1995.tb00145.x · Cited by 174
The Wake-Promoting Hypocretin–Orexin Neurons Are in an Intrinsic State of Membrane Depolarization
Eggermann, E., Bayer, L., Serafin, M., Saint-Mleux, B., Bernheim, L., Machard, D., Jones, B. E., & Mühlethaler, M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01557.2003 · Cited by 173
Wimo, A., Reed, C. C., Dodel, R., Belger, M., Jones, R. W., Happich, M., Argimon, J. M., Bruno, G., Novick, D., Vellas, B., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122392 · Cited by 162
CSF biomarkers predict rate of cognitive decline in Alzheimer disease
Kester, M. I., van der Vlies, A. E., Blankenstein, M. A., Pijnenburg, Y. A. L., van Elk, E. J., Scheltens, P., & van der Flier, W. M. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bd8271 · Cited by 159
Bianchetti, A., Scuratti, A., Zanetti, O. O., Binetti, G. G., Frisoni, G. B., Magni, E., & Trabucchi, M. (1995) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106930 · Cited by 145
Orexin Neurons Are Necessary for the Circadian Control of REM Sleep
Kántor, S., Mochizuki, T., Janisiewicz, A. M., Clark, E. L., Nishino, S., & Scammell, T. E. (2009) · SLEEP · doi:10.1093/sleep/32.9.1127 · Cited by 115
Activation of the basal forebrain by the orexin/hypocretin neurones
Arrigoni, E., Mochizuki, T., & Scammell, T. E. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.02036.x · Cited by 109
Altered CSF Orexin and α-Synuclein Levels in Dementia Patients
Wennström, M., Londos, E., Minthon, L., & Nielsen, H. M. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-111655 · Cited by 104
Increased hypocretin-1 levels in cerebrospinal fluid after REM sleep deprivation
Pedrazzoli, M., D’Almeida, V., Martins, P. J. F., Machado, R. B., Lin, L., Nishino, S., Tufik, S., & Mignot, E. J.-M. (2003) · Brain Research · doi:10.1016/j.brainres.2003.09.032 · Cited by 90
Schmidt, F. M., Kratzsch, J., Gertz, H., Tittmann, M., Jahn, I., Pietsch, U., Kaisers, U. X., Thiery, J., Hegerl, U., & Schönknecht, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063136 · Cited by 89
Slow-wave sleep, acetylcholine, and memory consolidation
Power, A. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400237101 · Cited by 76
Slats, D., Claassen, J. A. H. R., Lammers, G. J., Melis, R. J. F., Verbeek, M. M., & Overeem, S. (2012) · Current Alzheimer Research · doi:10.2174/156720512804142840 · Cited by 74
Stefani, A., Martorana, A., Bernardini, S., Panella, M., Mercati, F., Orlacchio, A., & Pierantozzi, M. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.09.014 · Cited by 63
Self-citationFetveit, A., & Bjorvatn, B. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1587 · Cited by 47
CSF beta‐amyloid levels are altered in narcolepsy: a link with the inflammatory hypothesis?
Liguori, C., Placidi, F., Albanese, M., Nuccetelli, M., Izzi, F., Marciani, M. G., Mercuri, N. B., Bernardini, S., & Romigi, A. (2014) · Journal of Sleep Research · doi:10.1111/jsr.12130 · Cited by 46
Self-citationHypocretin in cerebrospinal fluid is positively correlated with Tau and pTau
Deuschle, M., Schilling, C., Leweke, F. M., Enning, F., Pollmächer, T., Esselmann, H., Wiltfang, J., Frölich, L., & Heuser, I. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.12.036 · Cited by 44
Kundermann, B., Thum, A., Rocamora, R., Haag, A., Krieg, J.-C., & Hemmeter, U. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.07.008 · Cited by 42
Increased Levels of Soluble LR11 in Cerebrospinal Fluid of Patients with Alzheimer Disease
Ikeuchi, T., Hirayama, S., Miida, T., Fukamachi, I., Tokutake, T., Ebinuma, H., Takubo, K., Kaneko, H., Kasuga, K., Kakita, A., et al. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000315539 · Cited by 42
Sancesario, G. M., Esposito, Z., Nuccetelli, M., Bernardini, S., Sorge, R. P., Martorana, A., Federici, G., Bernardi, G., & Sancesario, G. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.028 · Cited by 41
Self-citationReduced Orexin-A Levels in Frontotemporal Dementia: Possible Association With Sleep Disturbance
Çoban, A., Bılgıç, B., Lohmann, E., Küçükali, C. İ., Şenel, G. B., Karadeniz, D., Hanagasi, H. A., Tüzün, E., & Gurvit, H. I. (2013) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513494453 · Cited by 38
Mallick, B. N., & Joseph, M. M. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01400-x · Cited by 30
Cited by
Mander, B. A., Winer, J. R., & Walker, M. P. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.004 · Cited by 1,185
Association between circadian rhythms and neurodegenerative diseases
Leng, Y., Musiek, E. S., Hu, K., Cappuccio, F. P., & Yaffe, K. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30461-7 · Cited by 654
Wang, C., & Holtzman, D. M. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0478-5 · Cited by 615
Implications of sleep disturbance and inflammation for Alzheimer's disease dementia
Irwin, M. R., & Vitiello, M. V. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30450-2 · Cited by 578
β-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation
Mander, B. A., Marks, S. M., Vogel, J. W., Rao, V., Lu, B., Saletin, J. M., Ancoli-Israel, S., Jagust, W. J., & Walker, M. P. (2015) · Nature Neuroscience · doi:10.1038/nn.4035 · Cited by 569
Metadata
- Authors
- Liguori, C., Romigi, A., Nuccetelli, M., Zannino, S., Sancesario, G., Martorana, A., Albanese, M., Mercuri, N. B., Izzi, F., Bernardini, S., Nitti, A., Sancesario, G. M., Sica, F., Marciani, M. G., & Placidi, F.
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2014-12-01
- Volume
- 71
- Issue
- 12
- Pages
- 1498
- ISSN
- 2168-6149 (ISSN-L)
- OpenAlex
- W2015603515
- Cited by
- 352
- References
- 44
- FWCI
- 10.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.